Genetic testing specialist 23andMe has launched a strategic review that could result in a sale of the company, after months of speculation about its future. The company's board has formed a ...

The group's genome-wide association study of 130,153 U.S.-based 23andMe research participants was compared with a similar UK Biobank database of 334,649 U.K. residents. The comparison revealed ...

Anna Wojcicki, the CEO of DNA testing app 23andMe that was sold for $6billion, is trying to buy the company back for just $75million. The troubled company was worth billions six years ago but now ...

Anne Wojcicki is at it again. After a failed attempt to buy back the DNA testing company she cofounded, the CEO has made another offer to gain control of 23andMe. But if the sale goes through ...

GWAS refers to genome-wide association study ... from an analysis of around one million people in collaboration with 23andMe which is a US-based genomics and biotechnology company.

23andMe's big push into drug development, announced with great fanfare almost a decade ago, has ended with a whimper and sweeping job losses. The company that made its name by providing saliva ...

Genome-wide association studies (GWAS) help scientists understand the inheritance patterns of disorders on a global scale. But can we make predictions from these studies? Only a few years ago ...